Your browser doesn't support javascript.
loading
Therapeutic Efficacy of 213Bi-labeled sdAbs in a Preclinical Model of Ovarian Cancer.
Dekempeneer, Yana; Caveliers, Vicky; Ooms, Maarten; Maertens, Dominic; Gysemans, Mireille; Lahoutte, Tony; Xavier, Catarina; Lecocq, Quentin; Maes, Ken; Covens, Peter; Miller, Brian W; Bruchertseifer, Frank; Morgenstern, Alfred; Cardinaels, Thomas; D'Huyvetter, Matthias.
Afiliación
  • Dekempeneer Y; Institute for Nuclear Materials Science, Belgian Nuclear Research Center (SCK CEN), 2400 Mol, Belgium.
  • Caveliers V; In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel (VUB), 1090 Brussels, Belgium.
  • Ooms M; In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel (VUB), 1090 Brussels, Belgium.
  • Maertens D; Department of Nuclear Medicine, UZ Brussel, 1090 Brussels, Belgium.
  • Gysemans M; Institute for Nuclear Materials Science, Belgian Nuclear Research Center (SCK CEN), 2400 Mol, Belgium.
  • Lahoutte T; Institute for Nuclear Materials Science, Belgian Nuclear Research Center (SCK CEN), 2400 Mol, Belgium.
  • Xavier C; Institute for Nuclear Materials Science, Belgian Nuclear Research Center (SCK CEN), 2400 Mol, Belgium.
  • Lecocq Q; In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel (VUB), 1090 Brussels, Belgium.
  • Maes K; Department of Nuclear Medicine, UZ Brussel, 1090 Brussels, Belgium.
  • Covens P; In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel (VUB), 1090 Brussels, Belgium.
  • Miller BW; Laboratory for Molecular and Cellular Therapy, Vrije Universiteit Brussel (VUB), 1050 Brussels, Belgium.
  • Bruchertseifer F; Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel (VUB), 1050 Brussels, Belgium.
  • Morgenstern A; In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel (VUB), 1090 Brussels, Belgium.
  • Cardinaels T; Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado 80045, United States.
  • D'Huyvetter M; Directorate for Nuclear Safety and Security, European Commission-Joint Research Centre, Karlsruhe 76344, Germany.
Mol Pharm ; 17(9): 3553-3566, 2020 09 08.
Article en En | MEDLINE | ID: mdl-32787284
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Radioisótopos / Bismuto / Radiofármacos / Anticuerpos de Dominio Único Límite: Animals / Female / Humans Idioma: En Revista: Mol Pharm Asunto de la revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Bélgica
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Radioisótopos / Bismuto / Radiofármacos / Anticuerpos de Dominio Único Límite: Animals / Female / Humans Idioma: En Revista: Mol Pharm Asunto de la revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Bélgica